Tuberculosis

Senior Director Infectious Diseases Cluster - USA

Pedro G. Suarez, MD, is a public health expert with nearly 30 years of experience developing, managing, implementing, and advising public health programs focused on TB, leprosy, and TB/HIV control. His work spans across 25 countries, including those in Latin America, the Caribbean, Africa, and the Middle East.

Muluken Melese Aseresa

Senior Technical Advisor for TB and HIV - USA

Muluken Melese Aseresa is a medical doctor and a public health professional with more than 20 years of clinical, project management, and research experience.

Mohammad Rashidi

Challenge TB Project Director - Afghanistan

Mohammad Khakerah Rashidi has 30 years of experience in public health and health systems in Afghanistan. He joined MSH in 2004 and is currently responsible for developing Afghanistan’s strategic roadmap for the organization. He provides technical leadership and strategic guidance to the health system, specifically with TB-related projects, and develops and maintains partnerships at the national level.

Dr. Berhanemeskal Assefa

Principal Technical Advisor - Ethiopia

Berhanemeskal Assefa has more than 30 years of clinical and managerial experience in medicine and public health, and has been trained widely in the areas of TB, TB/HIV, MDR-TB, management and leadership, and health systems strengthening.

Alaine Nyaruhirira

Senior Laboratory Technical Advisor - South Africa

Alaine Umubyeyi Nyaruhirira has 19 years of combined experience as a lecturer, researcher, and public health professional. She is currently the senior laboratory advisor for MSH, providing technical support to the national laboratory networks of several countries in sub-Saharan Africa to build capacity in implementing TB and HIV-related services.

Andre Zagorski

Principal Technical Advisor - USA

Andre Zagorski is senior principal technical advisor in MSH’s Pharmaceuticals and Health Technologies (PHT) Group, in charge of developing TB strategies and interventions to ensure universal access to anti-TB medicines, regimens and new technologies in line with the USAID and WHO goals of ending the TB epidemic.

Tuberculosis

Pages